top of page
희귀유전질환심포지엄조직위원회
Rare Genetic Disease Symposium Organizing Committee
LAST SYMPOSIUM
Last Symposium Information
%EC%A0%9C6%ED%9A%8C%20%ED%9D%AC%EA%B7%80%EC%9C%A0%EC%A0%84%EC%A7%88%ED%99%98%20%EC%8B%AC%ED%8F%AC%EC%A7%80%EC%97%84%20%ED%8F%AC%EC%8A%A4%ED%84%B0.png)
6th Rare Genetic Diseases Symposium
Date
Venue
September 22-23, 2025
Busan BEXCO Convention Hall, Room 107-110
Title
Work together for New world without Rare Genetic diseases
Session
- How to collaborate with Korean R&D Community
- Basic Research for Neuromuscular Diseases
- Clinical Approval
- Regulatory Affairs
- Company & Foundation
5th Rare Genetic Diseases Symposium
Date
Venue
October 24-25, 2024
usan BEXCO Convention Center, Exhibition Hall 2, Room 121-124
Title
Work together for New world without Rare Genetic diseases
Session
-Regulatory Strategy for New Drug for Rare Genetic Diseases
-Basic Research for Rare Genetic Diseases
-Development New Drug for Rare Genetic Diseases
-Funding and Foundation of Rare Genetic Diseases
4th Rare Genetic Diseases Symposium
Date
Venue
November 16-17, 2023
Nongshim Hotel Busan Daecheong Hall, Sapphire Hall
Title
Development of new drugs for rare neuropathy
Session
-Overview of rare disease treatments in Korea
-Academic approach of neuromuscular disease
-Clinical aspect of rare genetic diseases
-Bio-venture and investment
-Regulation and approval
-Panel discussion (CMC, Nonclinical, Clinical, Regulatory)
3rd Rare Genetic Diseases Symposium
Date
Venue
October 25-26, 2022
Busan Port International Exhibition Convention Center 5th floor Event Hall
Title
Status of rare genetic diseases worldwide and development strategies for treatment
Session
-Overview
-CMC & Nonclinical
-US FDA Approval of New Drug
-Rare Disease Basic Research
-Rare Genetic Disease Bio-Venture
-Accelerating Drug Development Key-Issue
2nd Rare Genetic Diseases Symposium
Date
Venue
August 26, 2019
Pusan National University Induk Hall Conference Room
Title
Finding the pathogenesis and treatment methods of incurable diseases
Session
-Oraphan Drug Development and approval:
A Regulatory Perspective
-Rare Disease Drug Development from a Nonclinical Perspective
bottom of page